Stay updated on GEMINI 1 Tolebrutinib Clinical Trial
Sign up to get notified when there's something new on the GEMINI 1 Tolebrutinib Clinical Trial page.

Latest updates to the GEMINI 1 Tolebrutinib Clinical Trial page
- Check8 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check15 days agoChange DetectedNew UI/text elements include a glossary toggle, a 'Last Update Submitted that Met QC Criteria' label, and a 'No FEAR Act Data' notice, while the page revision updated to v3.4.0 (replacing v3.3.4).SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page now displays Revision: v3.3.4 instead of Revision: v3.3.3; this is a metadata update and does not affect study content or functionality.SummaryDifference0.0%

- Check51 days agoChange DetectedLocations section updated with additions and deletions of multiple study sites across the US, Canada, and other countries, altering the geographic footprint of the trial. This may impact where participants can enroll and how the study is accessed.SummaryDifference2%

- Check74 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.3.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check81 days agoChange DetectedThe Publications section now notes that PubMed publications are automatically filled from PubMed and includes Revision: v3.3.1; the older manual PubMed listing language and Revision: v3.2.0 were removed.SummaryDifference0.0%

Stay in the know with updates to GEMINI 1 Tolebrutinib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GEMINI 1 Tolebrutinib Clinical Trial page.